Is it possible to rule out level II and level VB dissection in patients with metastatic papillary thyroid cancer?

BackgroundThe completeness of surgical resection is a key factor influencing outcomes in patients with papillary thyroid carcinoma (PTC) and regional lymph node metastases. However, the optimal extent of therapeutic lateral neck dissection remains a matter of debate This study aimed to assess the di...

Full description

Saved in:
Bibliographic Details
Main Authors: Tugba Matlim Ozel, Sezer Akbulut, Aykut Celik, Gorkem Yildiz, Hamit Yucel Barut, Fatih Mert Dogukan, Serkan Sari
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2025.1520539/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850033459568836608
author Tugba Matlim Ozel
Sezer Akbulut
Aykut Celik
Gorkem Yildiz
Hamit Yucel Barut
Fatih Mert Dogukan
Serkan Sari
author_facet Tugba Matlim Ozel
Sezer Akbulut
Aykut Celik
Gorkem Yildiz
Hamit Yucel Barut
Fatih Mert Dogukan
Serkan Sari
author_sort Tugba Matlim Ozel
collection DOAJ
description BackgroundThe completeness of surgical resection is a key factor influencing outcomes in patients with papillary thyroid carcinoma (PTC) and regional lymph node metastases. However, the optimal extent of therapeutic lateral neck dissection remains a matter of debate This study aimed to assess the diagnostic accuracy of preoperative ultrasonography (US) in detecting lateral lymph node metastasis (LLNM) in patients with PTC and to identify clinical and pathological factors predictive of metastases at levels II and V.MethodsThis retrospective study included consecutive patients with PTC who underwent comprehensive lateral neck dissection at a single tertiary center between June 2020 and July 2024.ResultsIn 63 patients, a total of 78 comprehensive lateral neck dissections were performed. Of the patients, 41 (65%) were male and 22 (35%) were female, with a median age of 37 years (range, 24–49 years). Lymph node metastases were identified in 46 (58.9%), at level II, 561 (78.2%) at level III, 60 (76.9%) at level IV, and 9 (11.5%) at level Vb. Metastasis to level IIb was detected in 5 dissections. Among the 9 patients with level Vb metastases, 7 (77.8%) had involvement of four different cervical levels. The specificity of US in identifying metastatic disease was notably high at both level II (80%) and level Vb (87%). Independent predictors of metastatic involvement at level II and level Vb lymph nodes was associated with extrathyroidal extension [level II: odds ratio (OR) 7.88, p=0.03; level V: OR 6.91, p=0.043] and a largest metastatic lateral lymph node size above 2 cm [level II: OR 18.58, p=0.03; level V: OR 11.32, p=0.03].ConclusionRoutine dissection of level IIa is recommended in N1b PTC due to high metastasis rates. However, level IIb dissection may be omitted in selected cases given its low metastasis rate and potential morbidity, with intraoperative frozen section serving as a useful guide. Similarly, level Vb dissection may be avoided when lateral lymph nodes are <2 cm, multilevel involvement is absent, and ultrasonographic findings are negative.
format Article
id doaj-art-57c40cdf61f14b32bca51ece88b50ae2
institution DOAJ
issn 1664-2392
language English
publishDate 2025-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj-art-57c40cdf61f14b32bca51ece88b50ae22025-08-20T02:58:11ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922025-08-011610.3389/fendo.2025.15205391520539Is it possible to rule out level II and level VB dissection in patients with metastatic papillary thyroid cancer?Tugba Matlim Ozel0Sezer Akbulut1Aykut Celik2Gorkem Yildiz3Hamit Yucel Barut4Fatih Mert Dogukan5Serkan Sari6Division of Endocrine Surgery, Department of General Surgery, University of Health Sciences Turkey, Basaksehir Cam and Sakura City Hospital, Istanbul, TürkiyeDivision of Endocrine Surgery, Department of General Surgery, University of Health Sciences Turkey, Basaksehir Cam and Sakura City Hospital, Istanbul, TürkiyeDivision of Endocrine Surgery, Department of General Surgery, University of Health Sciences Turkey, Basaksehir Cam and Sakura City Hospital, Istanbul, TürkiyeDivision of Endocrine Surgery, Department of General Surgery, University of Health Sciences Turkey, Basaksehir Cam and Sakura City Hospital, Istanbul, TürkiyeDepartment of Radiology, University of Health Sciences Turkey, Basaksehir Cam and Sakura City Hospital, Istanbul, TürkiyeDepartment of Pathology, University of Health Sciences Turkey, Basaksehir Cam and Sakura City Hospital, Istanbul, TürkiyeDivision of Endocrine Surgery, Department of General Surgery, University of Health Sciences Turkey, Basaksehir Cam and Sakura City Hospital, Istanbul, TürkiyeBackgroundThe completeness of surgical resection is a key factor influencing outcomes in patients with papillary thyroid carcinoma (PTC) and regional lymph node metastases. However, the optimal extent of therapeutic lateral neck dissection remains a matter of debate This study aimed to assess the diagnostic accuracy of preoperative ultrasonography (US) in detecting lateral lymph node metastasis (LLNM) in patients with PTC and to identify clinical and pathological factors predictive of metastases at levels II and V.MethodsThis retrospective study included consecutive patients with PTC who underwent comprehensive lateral neck dissection at a single tertiary center between June 2020 and July 2024.ResultsIn 63 patients, a total of 78 comprehensive lateral neck dissections were performed. Of the patients, 41 (65%) were male and 22 (35%) were female, with a median age of 37 years (range, 24–49 years). Lymph node metastases were identified in 46 (58.9%), at level II, 561 (78.2%) at level III, 60 (76.9%) at level IV, and 9 (11.5%) at level Vb. Metastasis to level IIb was detected in 5 dissections. Among the 9 patients with level Vb metastases, 7 (77.8%) had involvement of four different cervical levels. The specificity of US in identifying metastatic disease was notably high at both level II (80%) and level Vb (87%). Independent predictors of metastatic involvement at level II and level Vb lymph nodes was associated with extrathyroidal extension [level II: odds ratio (OR) 7.88, p=0.03; level V: OR 6.91, p=0.043] and a largest metastatic lateral lymph node size above 2 cm [level II: OR 18.58, p=0.03; level V: OR 11.32, p=0.03].ConclusionRoutine dissection of level IIa is recommended in N1b PTC due to high metastasis rates. However, level IIb dissection may be omitted in selected cases given its low metastasis rate and potential morbidity, with intraoperative frozen section serving as a useful guide. Similarly, level Vb dissection may be avoided when lateral lymph nodes are <2 cm, multilevel involvement is absent, and ultrasonographic findings are negative.https://www.frontiersin.org/articles/10.3389/fendo.2025.1520539/fulllateral lymph node metastasislevel V dissectionlevel II dissectionthyroid cancerlateral lymph node dissectionneck dissection
spellingShingle Tugba Matlim Ozel
Sezer Akbulut
Aykut Celik
Gorkem Yildiz
Hamit Yucel Barut
Fatih Mert Dogukan
Serkan Sari
Is it possible to rule out level II and level VB dissection in patients with metastatic papillary thyroid cancer?
Frontiers in Endocrinology
lateral lymph node metastasis
level V dissection
level II dissection
thyroid cancer
lateral lymph node dissection
neck dissection
title Is it possible to rule out level II and level VB dissection in patients with metastatic papillary thyroid cancer?
title_full Is it possible to rule out level II and level VB dissection in patients with metastatic papillary thyroid cancer?
title_fullStr Is it possible to rule out level II and level VB dissection in patients with metastatic papillary thyroid cancer?
title_full_unstemmed Is it possible to rule out level II and level VB dissection in patients with metastatic papillary thyroid cancer?
title_short Is it possible to rule out level II and level VB dissection in patients with metastatic papillary thyroid cancer?
title_sort is it possible to rule out level ii and level vb dissection in patients with metastatic papillary thyroid cancer
topic lateral lymph node metastasis
level V dissection
level II dissection
thyroid cancer
lateral lymph node dissection
neck dissection
url https://www.frontiersin.org/articles/10.3389/fendo.2025.1520539/full
work_keys_str_mv AT tugbamatlimozel isitpossibletoruleoutleveliiandlevelvbdissectioninpatientswithmetastaticpapillarythyroidcancer
AT sezerakbulut isitpossibletoruleoutleveliiandlevelvbdissectioninpatientswithmetastaticpapillarythyroidcancer
AT aykutcelik isitpossibletoruleoutleveliiandlevelvbdissectioninpatientswithmetastaticpapillarythyroidcancer
AT gorkemyildiz isitpossibletoruleoutleveliiandlevelvbdissectioninpatientswithmetastaticpapillarythyroidcancer
AT hamityucelbarut isitpossibletoruleoutleveliiandlevelvbdissectioninpatientswithmetastaticpapillarythyroidcancer
AT fatihmertdogukan isitpossibletoruleoutleveliiandlevelvbdissectioninpatientswithmetastaticpapillarythyroidcancer
AT serkansari isitpossibletoruleoutleveliiandlevelvbdissectioninpatientswithmetastaticpapillarythyroidcancer